Catastrophe bonds and other insurance-linked securities, which...
Category:
Non-Life
Latest
Russia certifier steps in after India drops safety cover for sanctioned ships
Major insurers and ship engine makers have already withdrawn cover...
South Africa’s Ramaphosa to sign health insurance bill into law just before electio
The law aims to provide healthcare to millions of poor citizens in...
Greensill creditors, led by Softbank, make $1.4 billion in claims to Australia parent
London-based group that collapsed earlier this month after losing insurance coverage for its debt repackaging business
Irdai lowers min cover, raises max cover under Arogya Sanjeevani policy
“In order to enhance the coverage available under Arogya Sanjeevani Policy, in partial modification of the extant guidelines, insurers shall mandatorily offer the sum insured between Rs 50,000 to Rs 10,00,000 under the standard product Arogya Sanjeevani w.e.f 1st May, 2021 or earlier,” Irdai said in a circular addressed to the general and standalone health insurers.
Chubb explores acquisition of $22 billion rival Hartford
Greenberg, 66, built the business into a mammoth insurer by combining Ace Ltd., the company he ran, with Chubb Corp. in a nearly $30 billion deal in 2016. The son of former American International Group Inc. CEO Maurice “Hank” Greenberg, he has transformed Chubb into a firm with huge footholds in both personal and commercial lines. The company calls itself the world’s largest publicly traded property and casualty insurer, with operations in 54 countries and more than 30,000 employees, according to its website.
Britain says expects financial services pact with EU this month
The City of London’s ties with the bloc were severed after Britain left the EU’s single market on Dec. 31 and the prospect of a pact has raised hopes in some quarters of at least a partial resumption of direct access to the continent’s financial markets.
“Monte Carlo Rendez-Vous de Septembre” canceled again due to Covid-19 Pandemic
Nevertheless, in the week of September 13 the organizing committee will organize conferences and round tables on the insurance and reinsurance industry.
Covid-19 vaccination drive to be extended in coming days: Harsh Vardhan
it is not scientifically necessary to administer the vaccine to each and every person in the country.
“Not each and every person in the world will be vaccinated. The prioritisation process is a dynamic process.
India has vaccinated 3.5 to 4 crore people so far and side effects of the vaccines has been recorded at 0.000432 per cent.
Lockdown is an option, says Maharashtra CM as Covid cases rise alarmingly
The state of 112 million people has already imposed a lockdown in some districts and put curbs on cinemas, hotels and restaurants until the end of the month. The rules were set to tighten further in Mumbai with mandatory testing to limit movement inside malls and cinemas, a senior official with the city’s COVID task-force said.
“I see lockdown as an option going ahead. But I trust people of the state to cooperate (and follow the COVID-19 norms voluntarily) like the last time,” he said.
Health claims should be processed within prescribed timelines:IRDAI
Where a claim is denied or repudiated, the communication about the denial or the repudiation should be made only by the Insurers(not by TPAS) by specifically stating the reasons for the denial or repudiation, while necessarily referring to the corresponding policy conditions. The insurer shall also furnish the grievance redressal procedures available with the Insurance company and with the Insurance Ombudsman along with the detailed addresses of the respective offices, said the IRDAI
UN says Covid may become ‘seasonal’ and peak around autumn-winter
Modelling studies anticipate that transmission of SARS-CoV-2, the virus that causes Covid-19 disease, “may become seasonal over time”.
Need to change Covaxin composition not felt yet due to vaccine’s good efficacy against mutant variants: Government
Covaxin’s efficacy against South African strain is ongoing, he said.
As for the Oxford-AstraZeneca COVID-19 vaccine Covishield, it has shown 74.6 per cent efficacy against the UK strain and has been shown to be effective against the Brazil strain.
However, its efficacy against the South Africa strain is just 10 per cent, the minister stated.
“The total number of cases with UK, South Africa and Brazil variants of the Covid virus in the country as on date is 400,” the Ministry said in a statement.